Recombinant Human NOV #abs00893

abs00893-5ug

1-2 Weeks

138

abs00893-20ug

1-2 Weeks

344

abs00893-1mg

1-2 Weeks

5058

Source

Escherichia coli.

Format

The concentrated solution was filtered through a 0.2 μm filter and then lyophilized. The solution was made up of 20 mM Tris-HCl with a pH of 8.6 and contained 150 mM NaCl. A highly similar content can be created by rearranging this information and stating that the concentrated solution was first filtered before it underwent lyophilization. The solution contained 20 mM Tris-HCl with a pH of 8.6 and was also composed of 150 mM NaCl.

Properties

aa_sequence

PVRQMCTSVQ EDQSDCTSAQ PAPTADGVRP GLCVDCGVSC ADPQEEDSSC TGSRCDADPY TSNVCGITVA EFVDGCNVDI RQPSGEYKFC QTVDRCGQFP CVLPENPACP PDVKKGEPVE WSCGICEDKP GGDSDAELSL AVLGLERAYT TEVPSEVDST CISVWEENAT CSGSGCGFMV NRTNRCQELM KQRMVCVREP EQPPDQTEKP TGKTCLSRKK LHKFAKQNTS YTHFKRCGVP SCDGRCTTNP EKFQALEENQ LRETGKNTKV M

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The amount of Recombinant HumanNOV determined by the LAL method is below 0.1 EU/μg. Let's create a rephrased version while maintaining the key information from the original text.

Activity

The standard and the tested substance are equally biologically active, indicating that the tested substance has the same level of biological activity as the standard. The ED value shows that the tested substance is fully active biologically, which is comparable to the standard.₅₀Our research has shown that the cell proliferation assay using murine Balb/c 3T3 cells indicates the potency of our product to be less than 1.0 μg/ml, displaying a highly specific activity of over 1000 IU/mg. We have thoroughly analyzed the data and are able to confidently report that our product is a highly effective substance with excellent cellular activity. Our findings validate the quality and efficacy of our product and we look forward to its application in various fields.

Reconstitution

We suggest briefly centrifuging the vial before opening to settle the contents at the bottom. Reconstitute the vial by adding sterile distilled water or an aqueous buffer with 0.1 % BSA to achieve a concentration of 0.1-1.0 mg/mL. Divide the resulting stock solution into separate working aliquots and keep them stored at -20 °C or below. Any further dilutions should be carried out using suitable buffered solutions.

Stability & Storage

For optimal storage of this lyophilized preparation, it is recommended to keep it at a temperature range of 2-8 °C. However, for long-term storage, it should be stored at -20 °C, preferably in a desiccated state. Once reconstituted, the preparation remains stable for a week when stored at 2-8 °C. To ensure maximum stability, it is advised to divide the reconstituted preparation into smaller portions and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

Target

Accession

P48745

Gene IDs

4856